167 related articles for article (PubMed ID: 22205960)
1. Multiplexed quantum dot labeling of activated c-Met signaling in castration-resistant human prostate cancer.
Hu P; Chu GC; Zhu G; Yang H; Luthringer D; Prins G; Habib F; Wang Y; Wang R; Chung LW; Zhau HE
PLoS One; 2011; 6(12):e28670. PubMed ID: 22205960
[TBL] [Abstract][Full Text] [Related]
2. Metastasis initiating cells in primary prostate cancer tissues from transurethral resection of the prostate (TURP) predicts castration-resistant progression and survival of prostate cancer patients.
Li Q; Li Q; Nuccio J; Liu C; Duan P; Wang R; Jones LW; Chung LW; Zhau HE
Prostate; 2015 Sep; 75(12):1312-21. PubMed ID: 25990623
[TBL] [Abstract][Full Text] [Related]
3. RANK- and c-Met-mediated signal network promotes prostate cancer metastatic colonization.
Chu GC; Zhau HE; Wang R; Rogatko A; Feng X; Zayzafoon M; Liu Y; Farach-Carson MC; You S; Kim J; Freeman MR; Chung LW
Endocr Relat Cancer; 2014 Apr; 21(2):311-26. PubMed ID: 24478054
[TBL] [Abstract][Full Text] [Related]
4. Convergent RANK- and c-Met-mediated signaling components predict survival of patients with prostate cancer: an interracial comparative study.
Hu P; Chung LW; Berel D; Frierson HF; Yang H; Liu C; Wang R; Li Q; Rogatko A; Zhau HE
PLoS One; 2013; 8(9):e73081. PubMed ID: 24066029
[TBL] [Abstract][Full Text] [Related]
5. Crosstalk between epithelial-mesenchymal transition and castration resistance mediated by Twist1/AR signaling in prostate cancer.
Shiota M; Itsumi M; Takeuchi A; Imada K; Yokomizo A; Kuruma H; Inokuchi J; Tatsugami K; Uchiumi T; Oda Y; Naito S
Endocr Relat Cancer; 2015 Dec; 22(6):889-900. PubMed ID: 26311513
[TBL] [Abstract][Full Text] [Related]
6. Sabutoclax, a Mcl-1 antagonist, inhibits tumorigenesis in transgenic mouse and human xenograft models of prostate cancer.
Jackson RS; Placzek W; Fernandez A; Ziaee S; Chu CY; Wei J; Stebbins J; Kitada S; Fritz G; Reed JC; Chung LW; Pellecchia M; Bhowmick NA
Neoplasia; 2012 Jul; 14(7):656-65. PubMed ID: 22904682
[TBL] [Abstract][Full Text] [Related]
7. Keratin 13 expression reprograms bone and brain metastases of human prostate cancer cells.
Li Q; Yin L; Jones LW; Chu GC; Wu JB; Huang JM; Li Q; You S; Kim J; Lu YT; Mrdenovic S; Wang R; Freeman MR; Garraway I; Lewis MS; Chung LW; Zhau HE
Oncotarget; 2016 Dec; 7(51):84645-84657. PubMed ID: 27835867
[TBL] [Abstract][Full Text] [Related]
8. Oncogenic miR-210-3p promotes prostate cancer cell EMT and bone metastasis via NF-κB signaling pathway.
Ren D; Yang Q; Dai Y; Guo W; Du H; Song L; Peng X
Mol Cancer; 2017 Jul; 16(1):117. PubMed ID: 28693582
[TBL] [Abstract][Full Text] [Related]
9. Activation of c-MET induces a stem-like phenotype in human prostate cancer.
van Leenders GJ; Sookhlall R; Teubel WJ; de Ridder CM; Reneman S; Sacchetti A; Vissers KJ; van Weerden W; Jenster G
PLoS One; 2011; 6(11):e26753. PubMed ID: 22110593
[TBL] [Abstract][Full Text] [Related]
10. Antitumor and antimetastatic activities of docetaxel are enhanced by genistein through regulation of osteoprotegerin/receptor activator of nuclear factor-kappaB (RANK)/RANK ligand/MMP-9 signaling in prostate cancer.
Li Y; Kucuk O; Hussain M; Abrams J; Cher ML; Sarkar FH
Cancer Res; 2006 May; 66(9):4816-25. PubMed ID: 16651437
[TBL] [Abstract][Full Text] [Related]
11. Receptor activator of NF-kappaB Ligand (RANKL) expression is associated with epithelial to mesenchymal transition in human prostate cancer cells.
Odero-Marah VA; Wang R; Chu G; Zayzafoon M; Xu J; Shi C; Marshall FF; Zhau HE; Chung LW
Cell Res; 2008 Aug; 18(8):858-70. PubMed ID: 18645583
[TBL] [Abstract][Full Text] [Related]
12. ETS1 induces transforming growth factor β signaling and promotes epithelial-to-mesenchymal transition in prostate cancer cells.
Rodgers JJ; McClure R; Epis MR; Cohen RJ; Leedman PJ; Harvey JM; ; Thomas MA; Bentel JM
J Cell Biochem; 2019 Jan; 120(1):848-860. PubMed ID: 30161276
[TBL] [Abstract][Full Text] [Related]
13. Effect of PI3K/Akt Signaling Pathway on the Process of Prostate Cancer Metastasis to Bone.
Zhu W; Hu X; Xu J; Cheng Y; Shao Y; Peng Y
Cell Biochem Biophys; 2015 May; 72(1):171-7. PubMed ID: 27040945
[TBL] [Abstract][Full Text] [Related]
14. Androgen deprivation causes epithelial-mesenchymal transition in the prostate: implications for androgen-deprivation therapy.
Sun Y; Wang BE; Leong KG; Yue P; Li L; Jhunjhunwala S; Chen D; Seo K; Modrusan Z; Gao WQ; Settleman J; Johnson L
Cancer Res; 2012 Jan; 72(2):527-36. PubMed ID: 22108827
[TBL] [Abstract][Full Text] [Related]
15. Epithelial to mesenchymal transition (EMT) in human prostate cancer: lessons learned from ARCaP model.
Zhau HE; Odero-Marah V; Lue HW; Nomura T; Wang R; Chu G; Liu ZR; Zhou BP; Huang WC; Chung LW
Clin Exp Metastasis; 2008; 25(6):601-10. PubMed ID: 18535913
[TBL] [Abstract][Full Text] [Related]
16. The androgen receptor negatively regulates the expression of c-Met: implications for a novel mechanism of prostate cancer progression.
Verras M; Lee J; Xue H; Li TH; Wang Y; Sun Z
Cancer Res; 2007 Feb; 67(3):967-75. PubMed ID: 17283128
[TBL] [Abstract][Full Text] [Related]
17. LIV-1 promotes prostate cancer epithelial-to-mesenchymal transition and metastasis through HB-EGF shedding and EGFR-mediated ERK signaling.
Lue HW; Yang X; Wang R; Qian W; Xu RZ; Lyles R; Osunkoya AO; Zhou BP; Vessella RL; Zayzafoon M; Liu ZR; Zhau HE; Chung LW
PLoS One; 2011; 6(11):e27720. PubMed ID: 22110740
[TBL] [Abstract][Full Text] [Related]
18. Epithelial-mesenchymal-transition regulators in prostate cancer: Androgens and beyond.
Nakazawa M; Kyprianou N
J Steroid Biochem Mol Biol; 2017 Feb; 166():84-90. PubMed ID: 27189666
[TBL] [Abstract][Full Text] [Related]
19. Sox2 is an androgen receptor-repressed gene that promotes castration-resistant prostate cancer.
Kregel S; Kiriluk KJ; Rosen AM; Cai Y; Reyes EE; Otto KB; Tom W; Paner GP; Szmulewitz RZ; Vander Griend DJ
PLoS One; 2013; 8(1):e53701. PubMed ID: 23326489
[TBL] [Abstract][Full Text] [Related]
20. Loss of SPDEF and gain of TGFBI activity after androgen deprivation therapy promote EMT and bone metastasis of prostate cancer.
Chen WY; Tsai YC; Yeh HL; Suau F; Jiang KC; Shao AN; Huang J; Liu YN
Sci Signal; 2017 Aug; 10(492):. PubMed ID: 28811384
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
